Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females
University of Connecticut · NCT07365514
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 45–70 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 1
- Target enrollment
- 159
- US sites recruiting
- 1
- Study start
- July 2026
- Record last updated
- July 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to evaluate the effects of blackcurrant (BC) supplementation on changes in bone density and gut microbiome composition in postmenopausal females.
Being studied: Blackcurrant (BC) extract; Blackcurrant (BC) extract; Placebo
Conditions: Postmenopausal Osteoporosis; Gut Microbiome; Menopause
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- postmenopausal (defined as no more than 10 years since final menstrual cycle) females aged 45-70 years
- not on hormone replacement therapy for at least one year before initiation of the study
- maintaining normal exercise level (\< 7 hours/week) and willing to avoid exercise for 24 hours prior to blood and stool sampling
- willing to ingest a dietary blackcurrant supplement or placebo (up to 1,176 mg/day, three 392mg capsules)
- willing to avoid other dietary supplements for the duration of the study
- willing to avoid intake of foods extremely rich in anthocyanins and fermented dairy products containing viable Bifidobacteria or Lactobacilli
- willing to have three blood draws, three stool collections, and three bone scans
Exclusion Criteria
- history of cardiovascular disease, osteoporosis, metabolic bone disease, cancer, diabetes mellitus, arthritis, or other chronic inflammatory diseases
- current smokers
- taking prescription medications known to alter bone and calcium metabolism
- taking anabolic agents such as parathyroid hormone or growth hormone, or steroid within 3 months before the start of the study
- taking medications that alter bleeding (such as antiplatelets or anticoagulants) or those with a bleeding disorder
- alcohol consumption exceeding 2 drinks/day (approximately 14g of ethanol per drink) or a total of 12/week
- those with planned surgery during the study period or within 2 weeks of ending the intervention
- those with sensitivities or allergies to any of the ingredients for the placebo (rice powder)
- planning a procedure that includes iodine, barium or nuclear medicine isotopes within the study period
- UConn students and/or employees who any key personnel teach or who report to any key personnel
- study key personnel, partners of key personnel, or dependents/relatives of any key personnel
Recruiting US locations
University of Connecticut, Department of Nutritional Sciences
Storrs, CT 06269
Site contact: Ock Chun, PhD · 860-486-6275 · ock.chun@uconn.edu
Study contacts (from the official record)
- Ock Chun, PhD · 860-486-6275 · ock.chun@uconn.edu
- Briana Nosal, MS · 860-878-0679 · briana.nosal@uconn.edu
Similar studies in Connecticut
All women’s health studies in Connecticut →- RecruitingPhase 2
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Regeneron Pharmaceuticals
- Location
- New Haven, CT + 9 other US sites
- Eligibility basics
- Ages 18–40 · Women only
- RecruitingPhase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Granata Bio Corporation
- Location
- Norwalk, CT + 14 other US sites
- Eligibility basics
- Ages 18–42 · Women only
- RecruitingHealthy volunteersPhase 2
Long Term Evaluation of Scapular-inserted Contraceptive Implants
Yale University
- Location
- New Haven, CT + 1 other US site
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteersPhase 4
Oral Contraceptive Pill (OCP) Pharmacogenomics
Yale University
- Location
- New Haven, CT + 1 other US site
- Eligibility basics
- Ages 18–45 · Women only